Tag Archives: Meeting report

CANTOS: a focus on inflammation and atherosclerosis A consistent criticism of the ESC congress in recent years has been that, outside of the chronic heart failure arena at least, the late breaker sessions have lacked headline-grabbing, big-hitting landmark trials. Not this year. “This is our 1994!” proclaimed chief investigator, Paul Ridker (Brigham and Women’s Hospital, Boston, USA), on presentation of the results of CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), drawing parallels with the practice-changing impact of the 4S (Scandinavian Simvastatin Survival Study) trial, which demonstrated the efficacy of statins

Report shows access to cardiac care is patchy in the UK A new UK-wide study, mapping disparities in access to cardiac care, has “major implications for provision of services throughout the UK” says Professor Keith Fox (University of Edinburgh) President, British Cardiovascular Society (BCS). The report, commissioned by the BCS, the British Heart Foundation and the Cardio & Vascular Coalition, shows that despite finding a marked increase in provision of the main cardiac treatments in the country, there were many parts of the UK where access was significantly below the levels expected. It also shows the UK being in the lower quartile fo